Eligible participants will be adults ( @years ) with type @ diabetes treated with insulin pump therapy and suboptimal glycaemic control ( glycated haemoglobin ( HbA@c ) @ % ( @mmol/mmol ) and @ % ( @mmol/mmol ) ) .